Emmanuel Dejardin
- Cancer Research top 1%
- NF-κB Signaling Pathways 26
- Immunology top 1%
- Immune Response and Inflammation 15
- interferon and immune responses 4
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions 5
- Molecular Biology top 5%
- Cell death mechanisms and regulation 10
- Natural product bioactivities and synthesis 3
- Ubiquitin and proteasome pathways 3
- Toxicology top 5%
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Douglas R. GreenUlrich MaurerCéline CharvetAllan S. WagmanVincent BoursNathalie DroinMarie‐Paule MervilleZhiwei Li
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (4 papers)Immunity (1 paper)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Emmanuel Dejardin
38 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 1.7k
- Immunology 1.8k
- Oncology 913
- Molecular Biology 2.1k
- Toxicology 49
Countries citing papers authored by Emmanuel Dejardin
This map shows the geographic impact of Emmanuel Dejardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Dejardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Dejardin more than expected).
Fields of papers citing papers by Emmanuel Dejardin
This network shows the impact of papers produced by Emmanuel Dejardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Dejardin. The network helps show where Emmanuel Dejardin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emmanuel Dejardin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 8 | |
| 4 | 2018 | 13 | |
| 5 | 2017 | 16 | |
| 6 | 2015 | 344 | |
| 7 | 2015 | 2 | |
| 8 | 2013 | 252 | |
| 9 | 2011 | 56 | |
| 10 | 2009 | 30 | |
| 11 | 2008 | 19 | |
| 12 | 2007 | 37 | |
| 13 | 2007 | 75 | |
| 14 | Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1breakdown → | 2006 | 705 |
| 15 | 2006 | 296 | |
| 16 | 2004 | 112 | |
| 17 | 2003 | 134 | |
| 18 | 2001 | 113 | |
| 19 | 1999 | 98 | |
| 20 | 1996 | 64 |
About Emmanuel Dejardin
Emmanuel Dejardin is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 38 papers that have together received 3.9k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (26 papers), Immune Response and Inflammation (15 papers), Cell death mechanisms and regulation (10 papers), Cytokine Signaling Pathways and Interactions (5 papers), interferon and immune responses (4 papers), Natural product bioactivities and synthesis (3 papers), Ubiquitin and proteasome pathways (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (1.7k citations), Immunology (1.8k citations) and Oncology (913 citations). Emmanuel Dejardin has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Douglas R. Green, Ulrich Maurer, Céline Charvet, Allan S. Wagman, Vincent Bours, Nathalie Droin, Marie‐Paule Merville, Zhiwei Li, Constantin Makris and Yixue Cao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.